Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . October 4th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Antiviral Therapy - Multiferon is an alternative for treating difficult chronic hepatitis C cases
Diagnostics - Specific patient circumstances should be considered prior to liver biopsy
Drug Addiction - Substance abuse programs would slow HCV transmissions among homeless men
Drug Development - Arsenic trioxide inhibits hepatitis C virus replication
Foodborne Disease - Uncooked deer meat consumption presents a risk for hepatitis E virus infection
Adverse Drug Effects - Sevoflurane exposure is associated with a case of infant hepatitis
Business Update - VScan exposure increases in the Caribbean
Chronic Hepatitis C Therapy - No patterns emerge with viral breakthrough during HCV combination therapy
Colon Cancer - Strong association of ARK5 with tumor invasion and metastasis
Drug Manufacture - Leukocyte chromosomal DNA backs interferon production in Escherichia coli
Embryonic Stem Cell Research - Cultivation of fetal human hepatocytes attempted in microfluidic environment
Endocrinology - Cell-specific betaC-activin expression characterized
HIV/AIDS Coinfection - Antiretroviral therapy is safe for women with HCV infection
Hepatitis - Strategies to manage patients with viral hepatitis discussed at conference
Hepatitis A - Fully automated test for Hepatitis A virus released
Hepatitis C Virus - CCR5-Delta32 and CCR2-V641 polymorphisms not related to HCV infection response
Hepatitis C Virus - Cirrhosis and hepatocellular carcinoma increasing despite HCV infection decline
Hepatitis C Virus - Dosing complete in phase 1a study of oral HCV protease inhibitor for hepatitis C
Hepatitis C Virus - Reference laboratory network selects hepatitis C virus genotyping reagents
Immunology - TGF-beta1 may be involved in the pathogenesis of chronic liver disease
Legal Issues - Biotechnology company challenges validity of Benitec's Australian patent
Macular Degeneration - Investigational New Drug application filed for macular degeneration trials
Mergers & Acquisitions - Pharma company completes sale of vaccines business to ID Biomedical
Multiple Sclerosis - Vaccine may be associated with increased risk of MS
RNA Research - Hepatitis C virus NS3 helicase RNA aptamers further diagnosis and research
Toxicology - Bisphenol A irreversibly inhibits some cytochrome P450 forms
Viral Genomics - Hepadnaviral DNA integration emerges where DNA damage is pre-existent
Virology - C-type lectins capture and transfer hepatitis C virus infectious virions
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
